About Sacem Pharmaceuticals
Sacem Pharmaceuticals is a Healthcare company. Manufacturing of pharmaceuticals, chemicals, and implants in India. It operates in the Healthcare and Chemicals & Materials sectors. Its Indian entity Sacem Pharmaceuticals Private Limited reported revenue of ₹6.13 Cr. Sacem Pharmaceuticals offers products and services including Medicines and Implants. Its focus areas include Pharmaceuticals, Manufacturing, Drug Manufacturing and Formulation Development.
Company details
Sacem Pharmaceuticals is recognized as a manufacturer of pharmaceuticals, chemicals, and dyes intermediates, with facilities established in India. Research in formulation development and sterile processing is conducted to support a diverse product portfolio, including tablets, capsules, injections, and implants. The companys efforts are directed towards meeting international standards through innovative technologies and collaborations. Manufacturing processes are managed in locations like Ranchi and Chandigarh, where progress in therapy and disease treatment is emphasized.
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Website sacem.in
- Legal Name Sacem Pharmaceuticals Pvt. Ltd
- Date of Incorporation 05 Jan, 2015
- Jurisdiction Ranchi, Jharkhand, India
- Indian entity revenue₹6.13 Cr
FY 2024 · -9% YoY
- Indian entity net profit₹9.8 Lakh
FY 2024 · 2% margin
- Indian entity EBITDA₹25.5 Lakh
FY 2024 · 4% margin
Associated legal entities of Sacem Pharmaceuticals
Sacem Pharmaceuticals operates through Sacem Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sacem Pharmaceuticals Private Limited CIN U51909JH2015PTC002573 | Active | 05 Jan 2015 | Ranchi, Jharkhand | ₹6.1 Cr | 5 | View details |
Products & Services of Sacem Pharmaceuticals
Sacem Pharmaceuticals offers a comprehensive portfolio of products and services, including Medicines and Implants.
Various forms of medicines, such as tablets and capsules, are produced for therapeutic purposes.
Orthopedic implants, including those for clavicle and elbow, are manufactured for medical applications.
Board of directors of Sacem Pharmaceuticals Private Limited (Sacem Pharmaceuticals)
Sacem Pharmaceuticals Private Limited is the primary company behind Sacem Pharmaceuticals. The board of Sacem Pharmaceuticals Private Limited currently have 5 directors; the longest-serving is Govind Kumar, appointed in 2015. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Govind Kumar DIN 07026075 | Director | 05 Jan 2015 | 11 yrs 10 mo | Sacem Pharmaceuticals Private Limited |
| Rupesh Kumar Agrawal DIN 07852056 | Director | 19 Jun 2017 | 9 yrs 4 mo | Sacem Pharmaceuticals Private Limited |
| Rita Choudhary DIN 08040349 | Director | 01 Mar 2019 | 7 yrs 8 mo | Sacem Pharmaceuticals Private Limited |
| Ram Krishna Samir DIN 08891966 | Director | 24 Sep 2020 | 6 yrs 1 mo | Sacem Pharmaceuticals Private Limited |
| Rakesh Kumar DIN 10163914 | Director | 01 Jun 2023 | 3 yrs 5 mo | Sacem Pharmaceuticals Private Limited |
Financials of Sacem Pharmaceuticals
Figures of Sacem Pharmaceuticals Private Limited, the primary company behind Sacem Pharmaceuticals, for FY 2024. Revenue was ₹6.13 Cr (-9% year on year). Net profit was ₹9.8 Lakh (2% margin). EBITDA was ₹25.5 Lakh (4% margin). Revenue has grown at a compounded annual rate of +32% over three years and +32% over five years.
- ₹6.13 CrRevenue · FY 2024 · -9% YoY
- ₹9.8 LakhNet profit · 2% margin
- ₹25.5 LakhEBITDA · 4% margin
- ₹40 LakhPaid-up capital
- +32%Revenue CAGR, 3 years
- +32%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sacem Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Sacem Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sacem Pharmaceuticals
The primary company behind Sacem Pharmaceuticals, Sacem Pharmaceuticals Private Limited, reported revenue of ₹6.13 Cr for FY 2024, down 9% year on year.
Sacem Pharmaceuticals is recognized as a manufacturer of pharmaceuticals, chemicals, and dyes intermediates, with facilities established in India. Research in formulation development and sterile processing is conducted to support a diverse product portfolio, including tablets, capsules, injections, and implants. The companys efforts are directed towards meeting international standards through innovative technologies and collaborations. Manufacturing processes are managed in locations like Ranchi and Chandigarh, where progress in therapy and disease treatment is emphasized.
Sacem Pharmaceuticals offers Medicines and Implants.
Sacem Pharmaceuticals operates through Sacem Pharmaceuticals Private Limited.
The legal entities of Sacem Pharmaceuticals currently have 5 directors, including Rupesh Kumar Agrawal, Rita Choudhary, Govind Kumar and others.